NCT04679961View on ClinicalTrials.gov

Deep Learning on 3D Cellular-resolution Tomogram

CompletedOBSERVATIONAL

Enrollment

107

Participants

Timeline

Start Date

December 21, 2020

Primary Completion Date

December 14, 2022

Study Completion Date

December 14, 2022

Conditions

Skin Diseases

Interventions

DEVICE

ApolloVue® S100 Image System (Apollo Medical Optics)

The device is an in vivo non-invasive optical coherence tomography and will be used to obtain at least 6 medical images of normal and lesional skin, respectively, for both experimental group and control group.

Trial Locations (1)

25160

Mackay Memorial Hospital, New Taipei City

All Listed Sponsors

collaborator

National Taiwan University

OTHER

lead

Mackay Memorial Hospital

OTHER

NCT04679961 - Deep Learning on 3D Cellular-resolution Tomogram | Biotech Hunter | Biotech Hunter